Homology Medicines Inc (DELISTED) (FIXX:DL)
0.9347
-15.76
(-94.40%)
USD |
NASDAQ |
Mar 25, 16:00
0.92
-0.01
(-1.57%)
After-Hours: 20:00
Homology Medicines Cash from Investing (Quarterly): 31.72M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 31.72M |
| September 30, 2023 | -22.76M |
| June 30, 2023 | 61.00M |
| March 31, 2023 | 31.37M |
| December 31, 2022 | 17.99M |
| September 30, 2022 | -108.22M |
| June 30, 2022 | -41.37M |
| March 31, 2022 | 168.31M |
| December 31, 2021 | 43.66M |
| September 30, 2021 | 4.524M |
| June 30, 2021 | -13.74M |
| March 31, 2021 | -85.24M |
| December 31, 2020 | -0.955M |
| September 30, 2020 | 38.84M |
| Date | Value |
|---|---|
| June 30, 2020 | 52.01M |
| March 31, 2020 | 115.00M |
| December 31, 2019 | -20.03M |
| September 30, 2019 | -13.14M |
| June 30, 2019 | -38.30M |
| March 31, 2019 | 19.67M |
| December 31, 2018 | 10.20M |
| September 30, 2018 | -45.26M |
| June 30, 2018 | -93.37M |
| March 31, 2018 | 6.64M |
| December 31, 2017 | -79.90M |
| September 30, 2017 | -0.2995M |
| June 30, 2017 | -0.4733M |
| March 31, 2017 | -0.8484M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-108.22M
Minimum
Sep 2022
168.31M
Maximum
Mar 2022
11.61M
Average
4.524M
Median
Sep 2021
Cash from Investing (Quarterly) Benchmarks
| Societal CDMO Inc (DELISTED) | -0.734M |
| AgeX Therapeutics Inc (DELISTED) | 0.00 |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -21.58M |
| Cash from Financing (Quarterly) | 0.014M |
| Free Cash Flow | -96.46M |
| Free Cash Flow Per Share (Quarterly) | -6.699 |
| Free Cash Flow Yield | -3.21K% |